Webinars Archive

Discover our educational webinars and video series

Our webinars

ASM Microbe 2019 Industry & Science Showcase

The Challenges and Opportunities in Combating Pertussis

Dr. Jacky Chow

Whooping cough caused by Bordetella is a reemerging disease with significant impact on public health. What have we learned about this persistent disease? Have we found a way to prevent and diagnose the disease effectively?

06/21/2019 45 min
2019 ASM Clinical Virology Symposium Industry and Science Workshop

Laboratory diagnosis of Bordetella infections: rapid, direct detection and differentiation of B. pertussis and B. parapertussis

Jim Dunn, PhD, D(ABMM)

Bordetella pertussis and B. parapertussis are Gram negative bacteria that cause highly contagious respiratory infections. Laboratory diagnosis of B. pertussis and B. parapertussis infections has historically relied on methods such as conventional culture, serology or direct fluorescent antibody testing; all of which are insensitive and time-consuming. Current molecular methods have improved to allow for direct testing of nasopharyngeal specimens in a rapid manner, which is important for prompt institution of antimicrobial therapy, infection control measures and public health reporting. Rapid molecular testing results with Simplexa Bordetella Direct will be presented.

05/06/2019 45 min
2019 ASM Clinical Virology Symposium Industry and Science Workshop

Rapid detection of Varicella Zoster Virus Central Nervous System Infections

Preeti Pancholi, PhD D(ABMM)

Varicella zoster virus (VZV) causes primary chickenpox infection as well as neurologic conditions, including encephalitis and meningitis. This workshop will cover laboratory testing for VZV focusing on central nervous system infections. Clinical study results will also be presented for DiaSorin Molecular’s Simplexa™ VZV Direct assay that detects VZV from CSF samples without extraction in about an hour.

05/06/2019 30 min

Ticks are currently considered to be second only to mosquitoes as vectors of human infectious diseases in the world. Each tick species has preferred environmental conditions and habitat that determine the geographic distribution of the ticks and, consequently, the risk areas for tick-borne diseases. Tick-borne diseases are becoming more frequently diagnosed as the cause of human infections as animal reservoirs and tick vectors have increased in numbers and humans have inhabited areas where reservoir and tick populations are high.

Ticks may become infected and harbor one or more disease-causing agents (e.g. bacteria, viruses, or parasites) and coinfection can also occur, compounding the difficulty in diagnosis and treatment. Co-infections often prove to cause worse symptoms than a single infection alone. In most cases, patients present severe atypical clinical manifestations, wider range of secondary symptoms, and longer recovery. Co-infections can be challenging to diagnose, as clinical features of tick-borne diseases often overlap. Identifying and treating polymicrobial infections are critical as morbidity and mortality increases substantially if there are delays in diagnosis and treatment.

04/24/2019 60 min
Hosted by: DiaSorin Molecular

Bordetella Pertussis: From Clinical Implications to the Right Diagnosis

Dr. Livia Berlinger

Dr. Livia Berlinger earned a PhD in Biology from the University of Zurich. She is a member of the Swiss Scientific Society of Infectious Diseases and has served as the head of Molecular Diagnostics for Bioanalytica AG in Luzern since 2014.

Bioanalytica represents a laboratory network serving public and private Hospitals since 1957 and has a strong presence in Switzerland. Bioanalytica provides consistent high-quality diagnostics at a national level thanks to a unified effort of more than forty clinicians, biologists and pharmacologists. In her role, Dr. Berlinger manages infectious diseases diagnostics to ensure continuous technological advancement, both in microbiology and virology.

In this seminar, Dr. Berlinger will present an overview of the challenges associated with Bordetella infection, with a specific focus on molecular diagnostics.

Recorded October 2018. Made available in April 2019.

04/17/2019 40 min
Hosted by: Labroots

Validation and Implementation of Quantitative Molecular Assays

Morgan A. Pence, PhD, D(ABMM)

Regulatory requirements for verification and validation are complex and often cause confusion among clinical laboratorians, especially in regards to quantitative molecular assays. This presentation will discuss verification and validation requirements as defined by the Clinical Laboratory Improvement Amendments (CLIA) and the College of American Pathologists (CAP). Calibrations and standards, including calibration, calibration verification, analytical measurement range (AMR) verification and the importance of quality standards, will also be discussed.

04/10/2019 60 min
Hosted by: Labroots

Influenza 2018-2019: Are you ready?

Jay M. Lieberman, MD

Appropriate treatment of patients with influenza depends on accurate and timely diagnosis, and early diagnosis can reduce the inappropriate use of antibiotics and provide the option of using antiviral therapy. Diagnostic tests available for influenza include viral culture, serology, rapid antigen testing, reverse transcription PCR, immunofluorescence assays, and rapid molecular assays. Molecular assays are increasingly becoming the diagnostic tests of choice.

11/08/2018 60 min
Presented at: AMP 2018 Annual Meeting and Expo

Update: The Latest in Molecular Testing for P. jirovecii and Group B Strep

Dr. Wallace Greene AND Dr. Raquel Martinez

Dr. Wallace Greene from Penn State College of Medicine, Milton S. Hershey Medical Center discusses converting Pneumocystis jirovecii testing from DFA to molecular.

Dr. Raquel Martinez from Geisinger Medical Laboratories discusses Group B Strep diagnostics and results from the clinical study for Simplexa™ Group B Strep Direct.

10/31/2018 47 min
Presented at: ESCV on September 24, 2018

Herpes Simplex Viral Infections: Clinical Overview and Diagnostic Implications

Maddalena Peghin, MD, PhD; Dr. David Boutolleau; Michelle Tabb, PhD

Maddalena Peghin, MD, PhD: Herpes Viruses Infections: a clinical overview

Dr. David Boutolleau: Molecular diagnosis of viral meningoencephalitis with the DiaSorin Simplexa solution: experience of the French National Reference Center for Herpesviruses

Michelle Tabb, PhD: A new comprehensive solution for molecular detection of herpetic simplex viruses infections